APO RESEARCH · REPORT
Polymeric Coatings for Drug Delivery
Polymeric coatings for drug delivery are drug-containing polymer layers engineered on a product surface to store an active pharmaceutical ingredient and govern its release to the surrounding tissue or fluid environment over a defined time window. The polymer functions as the structural matrix that immobilizes the drug and controls transport through mechanisms such as diffusion, polymer swelling, and, when bioresorbable chemistries are used, hydrolytic degradation, enabling release profiles that range from rapid transfer to sustained elution. In medical devices, these coatings are implemented as single-layer or multi-layer architectures, including matrix-dispersed and reservoir designs, and are built from durable polymers or bioresorbable polyesters.
Product & engineering
Understand the product.
Polymeric coatings for drug delivery are drug-containing polymer layers engineered on a product surface to store an active pharmaceutical ingredient and govern its release to the surrounding tissue or fluid environment over a defined time window. The polymer functions as the structural matrix that immobilizes the drug and controls transport through mechanisms such as diffusion, polymer swelling, and, when bioresorbable chemistries are used, hydrolytic degradation, enabling release profiles that range from rapid transfer to sustained elution. In medical devices, these coatings are implemented as single-layer or multi-layer architectures, including matrix-dispersed and reservoir designs, and are built from durable polymers or bioresorbable polyesters.
Selected research
Market Outlook & Growth Opportunities
Global Polymeric Coatings for Drug Delivery Market Outlook and Growth Opportunities 2026
Market perspective
Polymeric coatings for drug delivery are drug-containing polymer layers engineered on a product surface to store an active pharmaceutical ingredient and govern its release to the surrounding tissue or fluid environment over a defined time window. The polymer functions as the structural matrix that immobilizes the drug and controls transport through mechanisms such as diffusion, polymer swelling, and, when bioresorbable chemistries are used, hydrolytic degradation, enabling release profiles that range from rapid transfer to sustained elution. In medical devices, these coatings are implemented as single-layer or multi-layer architectures, including matrix-dispersed and reservoir designs, and are built from durable polymers or bioresorbable polyesters.
The global Polymeric Coatings for Drug Delivery market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Polymeric Coatings for Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Europe market for Polymeric Coatings for Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Asia Pacific market for Polymeric Coatings for Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Polymeric Coatings for Drug Delivery market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Polymeric Coatings for Drug Delivery market include Surmodics, Freudenberg Medical, Poly-Med, Harland Medical Systems, Evonik, AST Products, Incaptek, Corbion and DSM Biomedical, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Polymeric Coatings for Drug Delivery market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Polymeric Coatings for Drug Delivery and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Polymeric Coatings for Drug Delivery revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Polymeric Coatings for Drug Delivery market.
Polymeric Coatings for Drug Delivery Segment by Company
Surmodics
Freudenberg Medical
Poly-Med
Harland Medical Systems
Evonik
AST Products
Incaptek
Corbion
DSM Biomedical
Polymeric Coatings for Drug Delivery Segment by Type
Durable Polymer
Biodegradable Polymer
Polymeric Coatings for Drug Delivery Segment by Application
Cardiovascular (CV)
Neurovascular
Catheters and Indwelling Devices
Orthopedics and Surgical Implants
Polymeric Coatings for Drug Delivery Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Polymeric Coatings for Drug Delivery status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Polymeric Coatings for Drug Delivery key companies, revenue, market share, and recent developments.
3. To split the Polymeric Coatings for Drug Delivery breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Polymeric Coatings for Drug Delivery market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Polymeric Coatings for Drug Delivery significant trends, drivers, influence factors in global and regions.
6. To analyze Polymeric Coatings for Drug Delivery competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polymeric Coatings for Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polymeric Coatings for Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polymeric Coatings for Drug Delivery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Polymeric Coatings for Drug Delivery industry.
Chapter 3: Detailed analysis of Polymeric Coatings for Drug Delivery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Polymeric Coatings for Drug Delivery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Polymeric Coatings for Drug Delivery in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Durable Polymer
- Biodegradable Polymer
Applications
- Cardiovascular (CV)
- Neurovascular
- Catheters and Indwelling Devices
- Orthopedics and Surgical Implants
Companies covered
- Surmodics
- Freudenberg Medical
- Poly-Med
- Harland Medical Systems
- Evonik
- AST Products
- Incaptek
- Corbion
- DSM Biomedical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Polymeric Coatings for Drug Delivery Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Polymeric Coatings for Drug Delivery Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Polymeric Coatings for Drug Delivery Market Dynamics
- 2.1 Polymeric Coatings for Drug Delivery Industry Trends
- 2.2 Polymeric Coatings for Drug Delivery Industry Drivers
- 2.3 Polymeric Coatings for Drug Delivery Industry Opportunities and Challenges
- 2.4 Polymeric Coatings for Drug Delivery Industry Restraints
3 Polymeric Coatings for Drug Delivery Market by Company
- 3.1 Global Polymeric Coatings for Drug Delivery Company Revenue Ranking in 2025
- 3.2 Global Polymeric Coatings for Drug Delivery Revenue by Company (2021-2026)
- 3.3 Global Polymeric Coatings for Drug Delivery Company Ranking (2024-2026)
- 3.4 Global Polymeric Coatings for Drug Delivery Company Manufacturing Base and Headquarters
- 3.5 Global Polymeric Coatings for Drug Delivery Company Product Type and Application
- 3.6 Global Polymeric Coatings for Drug Delivery Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Polymeric Coatings for Drug Delivery Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Polymeric Coatings for Drug Delivery Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Polymeric Coatings for Drug Delivery Market by Type
- 4.1 Polymeric Coatings for Drug Delivery Type Introduction
- 4.1.1 Durable Polymer
- 4.1.2 Biodegradable Polymer
- 4.2 Global Polymeric Coatings for Drug Delivery Sales Value by Type
- 4.2.1 Global Polymeric Coatings for Drug Delivery Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Polymeric Coatings for Drug Delivery Sales Value by Type (2021-2032)
- 4.2.3 Global Polymeric Coatings for Drug Delivery Sales Value Share by Type (2021-2032)
5 Polymeric Coatings for Drug Delivery Market by Application
- 5.1 Polymeric Coatings for Drug Delivery Application Introduction
- 5.1.1 Cardiovascular (CV)
- 5.1.2 Neurovascular
- 5.1.3 Catheters and Indwelling Devices
- 5.1.4 Orthopedics and Surgical Implants
- 5.2 Global Polymeric Coatings for Drug Delivery Sales Value by Application
- 5.2.1 Global Polymeric Coatings for Drug Delivery Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Polymeric Coatings for Drug Delivery Sales Value by Application (2021-2032)
- 5.2.3 Global Polymeric Coatings for Drug Delivery Sales Value Share by Application (2021-2032)
6 Polymeric Coatings for Drug Delivery Regional Value Analysis
- 6.1 Global Polymeric Coatings for Drug Delivery Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Polymeric Coatings for Drug Delivery Sales Value by Region (2021-2032)
- 6.2.1 Global Polymeric Coatings for Drug Delivery Sales Value by Region: 2021-2026
- 6.2.2 Global Polymeric Coatings for Drug Delivery Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Polymeric Coatings for Drug Delivery Sales Value (2021-2032)
- 6.3.2 North America Polymeric Coatings for Drug Delivery Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Polymeric Coatings for Drug Delivery Sales Value (2021-2032)
- 6.4.2 Europe Polymeric Coatings for Drug Delivery Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Polymeric Coatings for Drug Delivery Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Polymeric Coatings for Drug Delivery Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Polymeric Coatings for Drug Delivery Sales Value (2021-2032)
- 6.6.2 South America Polymeric Coatings for Drug Delivery Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Polymeric Coatings for Drug Delivery Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Polymeric Coatings for Drug Delivery Sales Value Share by Country, 2025 VS 2032
7 Polymeric Coatings for Drug Delivery Country-level Value Analysis
- 7.1 Global Polymeric Coatings for Drug Delivery Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Polymeric Coatings for Drug Delivery Sales Value by Country (2021-2032)
- 7.2.1 Global Polymeric Coatings for Drug Delivery Sales Value by Country (2021-2026)
- 7.2.2 Global Polymeric Coatings for Drug Delivery Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.7.2 France Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.14.2 China Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.17.2 India Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Polymeric Coatings for Drug Delivery Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Polymeric Coatings for Drug Delivery Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Polymeric Coatings for Drug Delivery Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Surmodics
- 8.1.1 Surmodics Company Information
- 8.1.2 Surmodics Business Overview
- 8.1.3 Surmodics Polymeric Coatings for Drug Delivery Revenue and Gross Margin (2021-2026)
- 8.1.4 Surmodics Polymeric Coatings for Drug Delivery Product Portfolio
- 8.1.5 Surmodics Recent Developments
- 8.2 Freudenberg Medical
- 8.2.1 Freudenberg Medical Company Information
- 8.2.2 Freudenberg Medical Business Overview
- 8.2.3 Freudenberg Medical Polymeric Coatings for Drug Delivery Revenue and Gross Margin (2021-2026)
- 8.2.4 Freudenberg Medical Polymeric Coatings for Drug Delivery Product Portfolio
- 8.2.5 Freudenberg Medical Recent Developments
- 8.3 Poly-Med
- 8.3.1 Poly-Med Company Information
- 8.3.2 Poly-Med Business Overview
- 8.3.3 Poly-Med Polymeric Coatings for Drug Delivery Revenue and Gross Margin (2021-2026)
- 8.3.4 Poly-Med Polymeric Coatings for Drug Delivery Product Portfolio
- 8.3.5 Poly-Med Recent Developments
- 8.4 Harland Medical Systems
- 8.4.1 Harland Medical Systems Company Information
- 8.4.2 Harland Medical Systems Business Overview
- 8.4.3 Harland Medical Systems Polymeric Coatings for Drug Delivery Revenue and Gross Margin (2021-2026)
- 8.4.4 Harland Medical Systems Polymeric Coatings for Drug Delivery Product Portfolio
- 8.4.5 Harland Medical Systems Recent Developments
- 8.5 Evonik
- 8.5.1 Evonik Company Information
- 8.5.2 Evonik Business Overview
- 8.5.3 Evonik Polymeric Coatings for Drug Delivery Revenue and Gross Margin (2021-2026)
- 8.5.4 Evonik Polymeric Coatings for Drug Delivery Product Portfolio
- 8.5.5 Evonik Recent Developments
- 8.6 AST Products
- 8.6.1 AST Products Company Information
- 8.6.2 AST Products Business Overview
- 8.6.3 AST Products Polymeric Coatings for Drug Delivery Revenue and Gross Margin (2021-2026)
- 8.6.4 AST Products Polymeric Coatings for Drug Delivery Product Portfolio
- 8.6.5 AST Products Recent Developments
- 8.7 Incaptek
- 8.7.1 Incaptek Company Information
- 8.7.2 Incaptek Business Overview
- 8.7.3 Incaptek Polymeric Coatings for Drug Delivery Revenue and Gross Margin (2021-2026)
- 8.7.4 Incaptek Polymeric Coatings for Drug Delivery Product Portfolio
- 8.7.5 Incaptek Recent Developments
- 8.8 Corbion
- 8.8.1 Corbion Company Information
- 8.8.2 Corbion Business Overview
- 8.8.3 Corbion Polymeric Coatings for Drug Delivery Revenue and Gross Margin (2021-2026)
- 8.8.4 Corbion Polymeric Coatings for Drug Delivery Product Portfolio
- 8.8.5 Corbion Recent Developments
- 8.9 DSM Biomedical
- 8.9.1 DSM Biomedical Company Information
- 8.9.2 DSM Biomedical Business Overview
- 8.9.3 DSM Biomedical Polymeric Coatings for Drug Delivery Revenue and Gross Margin (2021-2026)
- 8.9.4 DSM Biomedical Polymeric Coatings for Drug Delivery Product Portfolio
- 8.9.5 DSM Biomedical Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst